Table 3. Type, incidence, and malignancy-free interval after liver transplantation.
| Number | Malignancy-free interval (years) | |||
|---|---|---|---|---|
| Median | Minimal | Maximal | ||
| De novo malignancy (N= 98) | ||||
| Oral cavity | 6 | 2.21 | 0.66 | 6.41 |
| Pharynx | 13 | 2.17 | 0.47 | 7.92 |
| Esophagus | 5 | 4.27 | 1.12 | 5.71 |
| Stomach | 3 | 6.59 | 2.25 | 6.66 |
| Small intestine | 1 | 2.11 | 2.11 | 2.11 |
| Colon | 2 | 1.54 | 1.26 | 1.83 |
| Rectum | 2 | 2.21 | 1.47 | 2.95 |
| Liver | 19 | 1.49 | 0.55 | 5.45 |
| Ampulla of Vater | 1 | 0.89 | 0.89 | 0.89 |
| Gallbladder and extrahepatic bile ducts | 1 | 4.96 | 4.96 | 4.96 |
| Pancreas | 1 | 3.95 | 3.95 | 3.95 |
| Ill-defined sites within the digestive organs and peritoneum | 1 | 14.08 | 14.08 | 14.08 |
| Larynx | 2 | 4.95 | 2.39 | 7.52 |
| Lung | 4 | 1.13 | 0.56 | 8.99 |
| Pleura | 1 | 1.89 | 1.89 | 1.89 |
| Connective tissue | 1 | 1.05 | 1.05 | 1.05 |
| Skin | 1 | 7.17 | 7.17 | 7.17 |
| Breast | 4 | 1.55 | 0.56 | 2.53 |
| Kaposi's sarcoma | 2 | 0.89 | 0.66 | 1.12 |
| Cervix uteri | 2 | 2.74 | 1.39 | 4.08 |
| Prostate | 6 | 3.09 | 0.85 | 9.47 |
| Bladder | 2 | 4.78 | 3.04 | 6.52 |
| Kidney | 1 | 0.57 | 0.57 | 0.57 |
| Brain | 3 | 1.27 | 0.99 | 4.89 |
| Thyroid gland | 1 | 7.44 | 7.44 | 7.44 |
| Non-Hodgkin's lymphoma | 9 | 2.27 | 0.58 | 4.90 |
| Hodgkin's disease | 1 | 3.53 | 3.53 | 3.53 |
| Lymphoid leukemia | 2 | 2.74 | 2.04 | 3.45 |
| Myeloid leukemia | 2 | 1.36 | 0.79 | 1.93 |
| Total | 99 | 2.11 | 0.47 | 14.08 |
| Recurrent malignancy (N= 186) | ||||
| Liver | 155 | 1.29 | 0.56 | 9.58 |
| Intrahepatic bile ducts | 5 | 2.15 | 1.65 | 2.71 |
| lymph nodes | 3 | 1.10 | 0.39 | 1.64 |
| Lung | 9 | 0.95 | 0.62 | 8.33 |
| Pleura | 1 | 2.47 | 2.47 | 2.47 |
| Peritoneum | 1 | 0.85 | 0.85 | 0.85 |
| Other digestive organs and spleen | 1 | 1.08 | 1.08 | 1.08 |
| Brain and spinal cord | 2 | 1.11 | 0.98 | 1.24 |
| Bone and bone marrow | 8 | 1.07 | 0.55 | 3.34 |
| Other specified sites | 1 | 1.99 | 1.99 | 1.99 |
| Total | 186 | 1.28 | 0.39 | 9.58 |